InMed Pharmaceuticals Inc (INM)
4.53
+0.03
(+0.67%)
USD |
NASDAQ |
Nov 26, 16:00
4.55
+0.02
(+0.44%)
After-Hours: 06:44
InMed Pharmaceuticals Enterprise Value: -2.33M for Nov. 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 26, 2024 | -2.33M |
| November 25, 2024 | -2.352M |
| November 22, 2024 | -2.237M |
| November 21, 2024 | -2.244M |
| November 20, 2024 | -2.546M |
| November 19, 2024 | -2.459M |
| November 18, 2024 | -2.538M |
| November 15, 2024 | -2.509M |
| November 14, 2024 | -1.935M |
| November 13, 2024 | -2.245M |
| November 12, 2024 | -1.964M |
| November 11, 2024 | -2.079M |
| November 08, 2024 | -2.195M |
| November 07, 2024 | -2.205M |
| November 06, 2024 | -2.337M |
| November 05, 2024 | -2.352M |
| November 04, 2024 | -2.093M |
| November 01, 2024 | -1.842M |
| October 31, 2024 | -1.764M |
| October 30, 2024 | -1.376M |
| October 29, 2024 | -1.418M |
| October 28, 2024 | -0.8397M |
| October 25, 2024 | -1.135M |
| October 24, 2024 | -1.708M |
| October 23, 2024 | -1.617M |
| Date | Value |
|---|---|
| October 22, 2024 | -1.323M |
| October 21, 2024 | -1.710M |
| October 18, 2024 | -2.387M |
| October 17, 2024 | -2.275M |
| October 16, 2024 | -2.540M |
| October 15, 2024 | -2.662M |
| October 14, 2024 | -2.822M |
| October 11, 2024 | -2.782M |
| October 10, 2024 | -2.782M |
| October 09, 2024 | -2.842M |
| October 08, 2024 | -2.802M |
| October 07, 2024 | -2.715M |
| October 04, 2024 | -2.886M |
| October 03, 2024 | -2.679M |
| October 02, 2024 | -2.642M |
| October 01, 2024 | -2.622M |
| September 30, 2024 | -2.422M |
| September 27, 2024 | -3.474M |
| September 26, 2024 | -3.474M |
| September 25, 2024 | -3.585M |
| September 24, 2024 | -3.470M |
| September 23, 2024 | -3.467M |
| September 20, 2024 | -3.038M |
| September 19, 2024 | -4.136M |
| September 18, 2024 | -4.090M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.861M
Minimum
Feb 16 2023
43.44M
Maximum
Jun 03 2020
5.706M
Average
1.786M
Median
Jul 06 2022
Enterprise Value Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| Venus Concept Inc | 33.10M |
| Atlas Global Brands Inc | -- |
| Aurinia Pharmaceuticals Inc | 898.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.678M |
| Revenue (Quarterly) | 1.265M |
| Total Expenses (Quarterly) | 3.019M |
| EPS Diluted (Quarterly) | -54.20 |
| Gross Profit Margin (Quarterly) | 39.02% |
| Profit Margin (Quarterly) | -132.7% |
| Earnings Yield | -1.44K% |
| Normalized Earnings Yield | -1457.58 |